Ocular Therapeutix, Inc SEC filings OCUL
Ocular Therapeutix, Inc has 865 filings in SEC EDGAR's recent list, going back to Mar 6, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 11, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 11, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 11, 2025 |
| DEFA14A | Additional proxy material | May 7, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 12, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 12, 2024 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 14, 2023 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 16, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 18, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2021 | Apr 13, 2021 |
| DEFA14A | Additional proxy material | Jun 15, 2020 | — |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 25, 2020 |
| DEFA14A | Additional proxy material | Apr 25, 2019 | — |
| DEF 14A | Proxy statement | Apr 25, 2019 | Jun 11, 2019 |
| DEFA14A | Additional proxy material | Apr 23, 2018 | — |
| DEF 14A | Proxy statement | Apr 23, 2018 | Jun 14, 2018 |
| DEF 14A | Proxy statement | Apr 20, 2017 | Jun 1, 2017 |
| DEF 14A | Proxy statement | Apr 22, 2016 | Jun 2, 2016 |
| DEFA14A | Additional proxy material | Apr 24, 2015 | — |
| DEF 14A | Proxy statement | Apr 24, 2015 | Jun 11, 2015 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCUL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1393434
- Former names
- I-THERAPEUTIX INC (until Jul 2, 2009)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.